Investigating the microRNA-mRNA regulatory network in acute myeloid leukemia.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28989535)

Published in Oncol Lett on July 28, 2017

Authors

Haiguo Zhang1,2, Chengfang Zhang3, Rui Feng1,4, Haixia Zhang5, Min Gao3, Ling Ye2

Author Affiliations

1: Department of Hematology, Qilu Hospital, Shandong University, Jinan, Shandong 250012, P.R. China.
2: Department of Hematology, Jining No. 1 People's Hospital, Jining, Shandong 272011, P.R. China.
3: Department of Clinical Laboratory, Jining No. 1 People's Hospital, Jining, Shandong 272011, P.R. China.
4: Department of Hematology, Yantai Yuhuangding Hospital, Yantai, Shandong 264000, P.R. China.
5: Department of Pharmacy, Yantai Yuhuangding Hospital, Yantai, Shandong 264000, P.R. China.

Articles cited by this

Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27

Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res (2003) 103.76

Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res (2002) 76.95

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood (2009) 23.52

Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol (1976) 13.98

Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta (2003) 7.85

GOEAST: a web-based software toolkit for Gene Ontology enrichment analysis. Nucleic Acids Res (2008) 6.91

KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res (2015) 6.44

GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists. Genome Biol (2007) 6.11

Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J Exp Med (2008) 5.97

miRTarBase: a database curates experimentally validated microRNA-target interactions. Nucleic Acids Res (2010) 5.72

The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML. Science (2010) 4.37

miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions. Nucleic Acids Res (2013) 4.19

Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications. J Clin Oncol (2011) 3.34

The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest (2002) 3.23

Clinical role of microRNAs in cytogenetically normal acute myeloid leukemia: miR-155 upregulation independently identifies high-risk patients. J Clin Oncol (2013) 2.86

The updated incidences and mortalities of major cancers in China, 2011. Chin J Cancer (2015) 2.85

Dysregulated gene expression networks in human acute myelogenous leukemia stem cells. Proc Natl Acad Sci U S A (2009) 2.76

Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA). Blood (2002) 2.71

High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study. Blood (2008) 2.63

Induction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes monocytic differentiation through combinatorial regulation. Leukemia (2009) 2.24

Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study. J Clin Oncol (2005) 2.16

Microarray analysis after RNA amplification can detect pronounced differences in gene expression using limma. BMC Genomics (2006) 2.04

Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16 to 60 years old with acute myeloid leukemia and normal cytogenetics: a study of the Acute Myeloid Leukemia Study Group Ulm. J Clin Oncol (2002) 1.91

Constitutive activation of the Wnt/beta-catenin signalling pathway in acute myeloid leukaemia. Oncogene (2005) 1.70

TIM-3 is a promising target to selectively kill acute myeloid leukemia stem cells. Cell Stem Cell (2010) 1.64

Incidence and prognosis of c-KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias. Br J Haematol (2003) 1.54

Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS. Blood (2012) 1.36

Plag1 and Plagl2 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH11. Blood (2004) 1.26

Transcriptional activation capacity of the novel PLAG family of zinc finger proteins. J Biol Chem (1998) 1.25

Cooperativity between mutations in tyrosine kinases and in hematopoietic transcription factors in AML. Leukemia (2002) 1.18

Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile. Blood (2013) 1.16

Functional implications of microRNAs in acute myeloid leukemia by integrating microRNA and messenger RNA expression profiling. Cancer (2011) 1.16

Identification of circulating microRNAs as potential biomarkers for detecting acute myeloid leukemia. PLoS One (2013) 1.08

Curcumin promotes apoptosis by activating the p53-miR-192-5p/215-XIAP pathway in non-small cell lung cancer. Cancer Lett (2014) 1.04

miR-125a regulates cell cycle, proliferation, and apoptosis by targeting the ErbB pathway in acute myeloid leukemia. Leuk Res (2014) 0.99

Downregulation of the Wnt inhibitor CXXC5 predicts a better prognosis in acute myeloid leukemia. Blood (2015) 0.97

MicroRNA-150 expression induces myeloid differentiation of human acute leukemia cells and normal hematopoietic progenitors. PLoS One (2013) 0.90

Curcumin inhibits cell proliferation and induces apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of PI3K/Akt signaling pathway. Oncol Rep (2015) 0.88

Prognostic factors in AML in relation to (ab)normal karyotype. Best Pract Res Clin Haematol (2009) 0.88

A 3-microRNA scoring system for prognostication in de novo acute myeloid leukemia patients. Leukemia (2014) 0.87

miR-155 and miR-484 Are Associated with Time to Progression in Metastatic Renal Cell Carcinoma Treated with Sunitinib. Biomed Res Int (2015) 0.84

Regulation of RAB5C is important for the growth inhibitory effects of MiR-509 in human precursor-B acute lymphoblastic leukemia. PLoS One (2014) 0.83

Gene function prediction based on the Gene Ontology hierarchical structure. PLoS One (2014) 0.82

Up-regulated miR-155-5p promotes cell proliferation, invasion and metastasis in colorectal carcinoma. Int J Clin Exp Pathol (2015) 0.81

Epidemiology of adult acute myeloid leukemia: Impact of exposures on clinical phenotypes and outcomes after therapy. Cancer Epidemiol (2015) 0.80

Adult acute leukemia. Curr Probl Cancer (1997) 0.79

Gene expression profile related to prognosis of acute myeloid leukemia. Oncol Rep (2007) 0.79

MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis. J Oral Pathol Med (2015) 0.77